Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B

被引:0
|
作者
Chang, Ting-Tsung
Chao, You-Chen
Wu, Shun-Sheng
Tan, Chee Kia
Rosmawati, Mohamed
Lee, Alice
George, Jacob
Brett-Smith, Helena
Zink, Richard
Neo, Boon-Leong
机构
[1] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[2] Tri Serv Gen Hosp, Taipei, Taiwan
[3] Changhua Christian Hosp Hosp, Changhua, Taiwan
[4] Singapore Gen Hosp, Singapore 0316, Singapore
[5] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia
[6] Concord Repatriation Gen Hosp, Concord, NSW, Australia
[7] Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead, NSW, Australia
[8] Bristol Myers Squibb Pharmaceut Res Inst, Wallingford, CT USA
[9] Bristol Myers Squibb Pharmaceut Res Inst, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A127 / A127
页数:1
相关论文
共 50 条
  • [21] Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B
    Jung Won Jeon
    Hyun Phil Shin
    Joung Il Lee
    Kwang Ro Joo
    Jae Myung Cha
    Jae Jun Park
    Jun Uk Lim
    Kyuseong Lim
    Sunyong Kim
    Digestive Diseases and Sciences, 2012, 57 : 1358 - 1365
  • [22] Efficacy and safety of entecavir and lamivudine in japanese adult patients with chronic hepatitis B infection: a phase 2 clinical trial
    Shindo, M.
    Chayama, K.
    Toyota, J.
    Fujiwara, K.
    Sugihara, J.
    Hayashi, N.
    Seriu, T.
    Omata, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S94 - S95
  • [23] Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy
    陆玮伦
    谢冬英
    姚集鲁
    姚光弼
    崔振宇
    张定凤
    吴磊
    中华肝脏病杂志, 2004, (07) : 50 - 52
  • [24] Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
    Antoine, C
    Landau, A
    Menoyo, V
    Duong, JP
    Duboust, A
    Glotz, D
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 384 - 385
  • [25] THE EFFICACY OF ENTECAVIR IN BOTH NAIVE AND LAMIVUDINE EXPERIENCED WITHOUT RESISTANCE CHRONIC HEPATITIS B PATIENTS
    Ahn, S. J.
    Hwang, J. A.
    Kim, K. B.
    Cho, H. J.
    Kim, S. S.
    Cheong, J. Y.
    Cho, S. W.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S433 - S433
  • [26] Efficacy and safety of adefovir dipivoxil treatment in patient with compensated chronic hepatitis B and decompensated chronic hepatitis B after lamivudine breakthrough
    Lee, Heon-Ju
    Eun, Jong-Ryul
    Choi, Sun-Taek
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A14
  • [27] Efficacy and safety of Adefovir Dipivoxil treatment in patient with compensated chronic hepatitis B and decompensated chronic hepatitis B after Lamivudine breakthrough
    Choi, J. -W.
    Park, Y. -S.
    Kim, K. -H.
    Eun, J. -R.
    Lee, H. -J.
    LIVER INTERNATIONAL, 2006, 26 : 53 - 53
  • [28] Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Heo, Nae-Yun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 449 - 454
  • [29] Hepatitis B surface antigen loss in antiviral-treated patients with HBeAg(+) chronic hepatits B (CHB) infection: Observations from antiviral-naive patients treated with entecavir (ETV) or lamivudine (LVD)
    Gish, Robert
    Chang, Ting-Tsung
    Lai, Ching-Lung
    de Man, Robert
    Gadano, Adrian
    Poordad, Fred
    Zhu, Jin
    Yang, Joanna
    Brett-Smith, Helena
    HEPATOLOGY, 2006, 44 (04) : 558A - 558A
  • [30] Efficacy and safety of entecavir (ETV) vs. adefovir (ADV) in chronic hepatitis B (CHB) patients with evidence of hepatic decompensation: ETV-048 study
    Liaw, Y. F.
    Raptopoulou-Gigi, M.
    Cheinquer, H.
    Sarin, S. K.
    Tanwandee, T.
    Leung, N.
    Myers, R. P.
    Brown, R. S., Jr.
    Bialkowska, J.
    Munafo, L.
    Chen, Y. C.
    Tang, S.
    Cooney, E.
    Dharane, P.
    Newman, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A125 - A125